We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

65 hedge funds and large institutions have $67.3M invested in Adverum Biotechnologies in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,027% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $131K

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

36% more capital invested

Capital invested by funds: $49.5M → $67.3M (+$17.8M)

12% more funds holding

Funds holding: 58 → 65 (+7)

1.13% more ownership

Funds ownership: 3.14% → 4.27% (+1.1%)

Holders
65
Holders Change
+7
Holders Change %
+12.07%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
23
Reduced
10
Closed
12
Calls
$1.48M
Puts
$131K
Net Calls
+$1.35M
Net Calls Change
+$1.36M

Top Buyers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
+$7.46M
2
RCMNY
Rubric Capital Management (New York)
New York
+$2.63M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.35M
4
Morgan Stanley
Morgan Stanley
New York
+$1.9M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.65M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.36M
2
EC
EcoR1 Capital
California
-$2.79M
3
VMI
VHCP Management II
New York
-$1.02M
4
OAM
Oxford Asset Management
United Kingdom
-$521K
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$350K
Name Holding Trade Value Shares
Change 		Change in
Stake
JAM
26
JW Asset Management
Florida
$625K – – –
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$486K +$457K +13,894 New
JP Morgan Chase
28
JP Morgan Chase
New York
$464K +$97.4K +2,960 +29%
RPAM
29
Rhenman & Partners Asset Management
Sweden
$445K -$88.8K -2,700 -18%
AAP
30
Ardsley Advisory Partners
Connecticut
$350K +$329K +10,000 New
Goldman Sachs
31
Goldman Sachs
New York
$341K +$320K +9,733 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$333K – – –
PAM
33
Panagora Asset Management
Massachusetts
$316K +$17.5K +531 +6%
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$310K -$10.2K -310 -3%
Northern Trust
35
Northern Trust
Illinois
$281K +$88.4K +2,685 +50%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$236K +$222K +6,750 New
SIM
37
Spark Investment Management
New York
$233K +$86K +2,612 +64%
Russell Investments Group
38
Russell Investments Group
United Kingdom
$193K -$40.6K -1,234 -19%
RJA
39
Raymond James & Associates
Florida
$172K +$161K +4,900 New
BFM
40
Boothbay Fund Management
New York
$170K +$160K +4,861 New
Citadel Advisors
41
Citadel Advisors
Florida
$165K +$122K +3,704 +365%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$143K +$7.17K +218 +6%
OAM
43
Oxford Asset Management
United Kingdom
$138K -$521K -15,845 -80%
Barclays
44
Barclays
United Kingdom
$120K +$98.7K +3,000 +674%
BCM
45
BlueCrest Capital Management
Jersey
$111K +$104K +3,169 New
DS
46
DRW Securities
Illinois
$105K +$98.7K +3,000 New
Simplex Trading
47
Simplex Trading
Illinois
$101K +$43.2K +1,313 +83%
RG
48
Redmile Group
California
$78K – – –
AGM
49
Alpine Global Management
New York
$72K +$68.1K +2,071 New
JMPWA
50
JP Morgan Private Wealth Advisors
California
$70K – – –
1
2
3 4

ADVM Hedge Fund Activity: Q4 2017 in Review

65 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2017, worth a combined $67.3M — up 36% from $49.5M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ADVM positions and 12 closed out — a net gain of 7 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was Highbridge Capital Management, adding an estimated $7.46M. The largest seller was Fidelity Investments, cutting an estimated $3.36M.

  • 65 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2017, up from 58 in Q3 2017.
  • Funds reported $67.3M of Adverum Biotechnologies stock for Q4 2017, up 36% quarter-over-quarter.
  • 19 funds opened new Adverum Biotechnologies positions in Q4 2017 and 12 closed out, a net change of +7 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2017 was Highbridge Capital Management, an estimated $7.46M added.
  • The largest Adverum Biotechnologies seller in Q4 2017 was Fidelity Investments, an estimated $3.36M sold.

Based on aggregated 13F filings for Q4 2017.